KIR3DL1 and neoplasm: A higher proportion of the mainly inhibitory KIR haplotype, AA, in the AML patients, along with a significantly lower KIR2DS3 in the patients exhibiting the Bx haplotype indicates to a potential genetic predisposition in the NK cells that allows for inefficient immune response and tumor escape in the setting of AML.